Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saudi Chemical CoSAU:2230 +1.73%81 Debt-to-EBITDA is 2.17 as of Jun. 2026, which is 68% below its 10-year median of 6.68. GuruFocus rates SAU:2230 with a GF Score™ of 81/100 and a GF Value™ of ﷼8.68 (Fairly Valued). The stock has 4 warning signs investors should review. Among 676 Drug Manufacturers companies, Saudi Chemical Co ranks worse than 57.4% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Saudi Chemical Co's Debt-to-EBITDA or its related term are showing as below:
SAU:2230'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.07 Med: 6.68 Max: 9.85
Current: 2.07
During the past 13 years, the highest Debt-to-EBITDA Ratio of Saudi Chemical Co was 9.85. The lowest was 2.07. And the median was 6.68.
SAU:2230's Debt-to-EBITDA is ranked worse than 57.4% of 676
companies
in the Drug Manufacturers industry
Industry Median: 1.64
vs SAU:2230: 2.07
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Saudi Chemical Co Debt-to-EBITDA Related Terms
Saudi Chemical Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Saudi Chemical Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:2230 vs ZTS, UTHR, VTRS: Debt-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Chemical Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saudi Chemical Co Debt-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saudi Chemical Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Saudi Chemical Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Saudi Chemical Co (SAU:2230) has a Debt-to-EBITDA of 2.17 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Saudi Chemical Co. This is 68% below median its historical median of 6.68. Over the past decade, Saudi Chemical Co's Debt-to-EBITDA has ranged from 2.07 to 9.85. According to the industry distribution chart, Saudi Chemical Co ranks #388 out of 676 companies in the Drug Manufacturers industry, placing it in the top 57.4%.
Is Saudi Chemical Co's Debt-to-EBITDA too high?
Saudi Chemical Co's current Debt-to-EBITDA of 2.17 is 68% below median its 10-year median of 6.68. Over the past 10 years, this metric has ranged from a low of 2.07 to a high of 9.85. The Drug Manufacturers industry median Debt-to-EBITDA is 1.64. Saudi Chemical Co's value of 2.17 is 32.3% above this industry median. Based on the distribution chart, Saudi Chemical Co ranks #388 out of 676 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Saudi Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Chemical Co's Debt-to-EBITDA compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Saudi Chemical Co ranks #388 out of 676 companies for Debt-to-EBITDA. This places Saudi Chemical Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.64. Saudi Chemical Co's value of 2.17 is 32.3% above this benchmark. Historically, Saudi Chemical Co's own Debt-to-EBITDA has ranged from 2.07 to 9.85 over the past decade. While the company's 10-year median is 6.68 vs. the industry median of 1.64, Saudi Chemical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.64, based on 676 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saudi Chemical Co's current Debt-to-EBITDA of 2.17 is 32.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Saudi Chemical Co. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saudi Chemical Co's current Debt-to-EBITDA is 2.17, which is 68% below median its own 10-year median of 6.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Saudi Chemical Co (SAU:2230) is currently considered Fairly Valued. The stock's GF Value™ is ﷼8.68, compared to a current price of ﷼8.24 — trading 5.1% below its estimated fair value. The current Debt-to-EBITDA is 2.17, which is 68% below median its 10-year median of 6.68 and 32.3% above the Drug Manufacturers industry median of 1.64. Saudi Chemical Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Saudi Chemical Co (SAU:2230), the current Debt-to-EBITDA is 2.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saudi Chemical Co (SAU:2230) Overvalued in 2026?
Based on GuruFocus' analysis, Saudi Chemical Co stock appears to be undervalued.
The current stock price of ﷼8.24 is trading 5.1% below its estimated GF Value™ of ﷼8.68.
GuruFocus considers Saudi Chemical Co to be Fairly Valued.
Key valuation signals for SAU:2230:
Debt-to-EBITDA: 2.17 (68% below median its 10-year median of 6.68)
GF Value™: ﷼8.68 vs. price of ﷼8.24 (5.1% below fair value)
Industry Position: 32.3% above the Drug Manufacturers median (#388 of 676)
No single metric tells the full story. See the SAU:2230 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saudi Chemical Co, along with its subsidiaries, is engaged in the manufacturing and distribution of explosives and their derivatives. Its other business operations include providing technical support services in explosions, wholesale and retail trading in medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools, and equipment, supplies of hospitals and medical centers, and the manufacture of ammonium nitrate. The company operates in three segments: Explosives, Medicines & medical supplies, and Production of Ammonium Nitrate. It generates the majority of its revenue from Medicines & medical supplies.
81GF Score
Get the complete analysis for SAU:2230
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:2230 has been successfully added to your 
